je.st
news
U.S. FDA approves Durata's acute bacterial skin infection drug
2014-05-24 01:29:08| Biotech - Topix.net
The U.S. Food and Drug Administration said on Friday it has approved a new drug to treat acute bacterial skin infections made by Durata Therapeutics Inc. Approval of the drug, Dalvance, follows a positive recommendation by the FDA's advisory committee, which also gave a favorable review to a rival product from Cubist Pharmaceuticals Inc. The FDA is ... (more)
Tags: skin
drug
acute
infection
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||